You have no items in your shopping cart.
- Item 1 of 1
Biotinylated Human IL-2 [orb2993791]Biotin
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 18.3 KDa. Observed: 16-18 KDa, reducing conditions
20 μg, 100 μg- Biotinylated Human IL-2RB [orb2993868]
Biotin
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 27.4 KDa. Observed: 35-45 KDa, reducing conditions
20 μg, 100 μg - Mouse IL-2RA [orb2994413]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 25.5 KDa. Observed: 40-60 KDa, reducing conditions
10 μg, 50 μg, 1 mg, 500 μg - Mouse IL-2RA [orb2994437]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 51.6 KDa. Observed: 60-90 KDa, reducing conditions
10 μg, 50 μg, 1 mg, 500 μg - Human IL-2RB [orb2994461]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 51.7 KDa. Observed: 60-80 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human IL-2RB [orb2994462]
Unconjugated
SEC-HPLC: Greater than 90% as determined by SEC-HPLC.(QC verified)
Predicted: 25.6 KDa. Observed: 35-40 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human IL-2RA [orb2994463]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 90% as determined by SEC-HPLC. (QC verified)
Predicted: 48.9 KDa. Observed: 60-80 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human IL-2RA [orb2994464]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 22.8 KDa. Observed: 35-44 KDa, reducing conditions
10 μg, 50 μg, 1 mg, 500 μg - Mouse IL-2RB [orb2993765]
Unconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 26.1 KDa. Observed: 40-60 KDa, reducing conditions
1 mg, 10 μg, 50 μg, 500 μg
